Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
The Phase 2b COPERNICUS Study of Subcutaneous Amivantamab with Lazertinib as First-Line Treatment, or with Chemotherapy as Second-Line Treatment, for EGFR-Mutated Non-Small Cell Lung Cancer: a Vodcast.
Journal: Oncology and therapy
Published: May 12, 2025
Cutaneous Toxicities With Amivantamab for Non-Small Cell Lung Cancer: A Practical Guide and Best Practices.
Journal: Clinical journal of oncology nursing
Published: September 26, 2024
Infusion-Related Reaction Management With Amivantamab for EGFR Exon 20 Insertion Mutation NSCLC: A Practical Guide for Advanced Practitioners.
Journal: Journal of the advanced practitioner in oncology
Published: September 20, 2024
Management of Patients with Metastatic Castration-Sensitive Prostate Cancer in the Real-World Setting in the United States.
Journal: The Journal of urology
Published: July 23, 2021
Identification of patients with metastatic castration-sensitive or metastatic castration-resistant prostate cancer using administrative health claims and laboratory data.
Journal: Current medical research and opinion
Published: January 21, 2021
Preserving Well-being in Patients With Advanced and Late Prostate Cancer.
Journal: Urology
Published: July 31, 2020
Moderate Renal Impairment Does Not Impact the Ability of CSL112 (Apolipoprotein A-I [Human]) to Enhance Cholesterol Efflux Capacity.
Journal: Journal of clinical pharmacology
Published: September 25, 2018
Pharmacokinetics and Safety of CSL112 (Apolipoprotein A-I [Human]) in Adults With Moderate Renal Impairment and Normal Renal Function.
Journal: Clinical pharmacology in drug development
Published: May 29, 2018
Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study.
Journal: Journal of thrombosis and thrombolysis
Published: March 28, 2018
CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: January 24, 2018
Last Updated: 09/26/2026